STAT3 signaling also plays a role in treatment-resistant prostate cancer phenotypes such as CRPC40, regulation of cancer stem cell phenotype41 as well as development of resistance to 2nd generation anti-androgen, ENZ42. Here, STAT3 is linked to prostate cancer.